Sections of Nephrology and Biomedical Proteomics
Max Rady College of Medicine
SR372-700 William Avenue
University of Manitoba
Winnipeg, Manitoba R3E 3J7
Dr. Ho’s research focuses on improving understanding of fundamental human responses to early renal injury, and developing new diagnostic or therapeutic targets to improve kidney transplant and patient outcomes. Her research interests include early detection of rejection and predicting kidney transplant outcomes, ischemia reperfusion injury and acute kidney injury, kidney transplant rejection, and non-invasive biomarkers. She is the principle investigator of the Manitoba Center for Proteomics and Systems Biology, and the Transplant Manitoba Adult Kidney Research Group. Her research uses proteomics and mass spectrometry, activity-based protein profiling. Dr. Ho is presently conducting an international multi-center clinical trial evaluating the effectiveness of the early treatment of rejection, as detected by urine chemokines, for improving kidney transplant outcomes.
Principle Investigator, Manitoba Center for Proteomics and Systems Biology
Principle Investigator, Transplant Manitoba Adult Kidney Research Group
My goal is to foster a continuous learning system within our transplant program, with the overriding objective to provide outstanding patient care to improve the health of Manitobans with end-stage kidney disease.
Dr. Julie Ho is a Professor of Internal Medicine (Sections of Nephrology and Biomedical Proteomics) at the University of Manitoba. She is a transplant nephrologist and clinician-scientist with the Transplant Manitoba Adult Kidney Program. She is also the Medical Director for the Transplant Manitoba Adult Kidney Program.